XRAY vs. WST

In the year-to-date period, XRAY achieves a -26.81% return, which is significantly higher than WST's -34.46% return. Over the past 10 years, XRAY has underperformed WST with an annualized return of -11.40%, while WST has yielded a comparatively higher 14.88% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for DENTSPLY SIRONA Inc. (XRAY) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current XRAY Sharpe Ratio is -1.23, which is lower than the WST Sharpe Ratio of -0.82. The chart below compares the historical Sharpe Ratios of XRAY and WST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

XRAY's dividend yield for the trailing twelve months is around 4.65%, more than WST's 0.29% yield.

The maximum XRAY drawdown since its inception was -80.50%, which is greater than WST's maximum drawdown of -59.29%. Use the drawdown chart below to compare losses from any high point for XRAY and WST. For additional features, visit the drawdowns tool.

DENTSPLY SIRONA Inc. (XRAY) has a higher volatility of 17.03% compared to West Pharmaceutical Services, Inc. (WST) at 15.01%. This indicates that XRAY's price experiences larger fluctuations and is considered to be riskier than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between DENTSPLY SIRONA Inc. and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.